HIF-hypoxia signaling in skeletal muscle physiology and fibrosis

被引:49
作者
Valle-Tenney, Roger [1 ,2 ]
Rebolledo, Daniela [1 ,3 ,4 ]
Jose Acuna, Maria [1 ,4 ]
Brandan, Enrique [1 ,2 ,5 ,6 ]
机构
[1] CARE Chile UC, Ctr Envejecimiento & Regenerac, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile
[3] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile
[4] Univ Bernardo O Higgins, CIBQA, Santiago, Chile
[5] Fdn Ciencia & Vida, Santiago, Chile
[6] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cell & Mol Biol, Santiago, Chile
关键词
Muscle fibrosis; Hypoxia; Vasculature; CCN2; CTGF; Renin-angiotensin system; TISSUE-GROWTH-FACTOR; RENIN-ANGIOTENSIN SYSTEM; INDUCIBLE FACTOR 1-ALPHA; NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; NUCLEUS PULPOSUS; GENE-EXPRESSION; MOUSE MODEL; FACTOR-I;
D O I
10.1007/s12079-020-00553-8
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Hypoxia refers to the decrease in oxygen tension in the tissues, and the central effector of the hypoxic response is the transcription factor Hypoxia-Inducible Factor alpha (HIF1-alpha). Transient hypoxia in acute events, such as exercising or regeneration after damage, play an important role in skeletal muscle physiology and homeostasis. However, sustained activation of hypoxic signaling is a feature of skeletal muscle injury and disease, which can be a consequence of chronic damage but can also increase the severity of the pathology and worsen its outcome. Here, we review evidence that supports the idea that hypoxia and HIF-1 alpha can contribute to the establishment of fibrosis in skeletal muscle through its crosstalk with other profibrotic factors, such as Transforming growth factor beta (TGF-beta), the induction of profibrotic cytokines expression, as is the case of Connective Tissue Growth Factor (CTGF/CCN2), or being the target of the Renin-angiotensin system (RAS).
引用
收藏
页码:147 / 158
页数:12
相关论文
共 135 条
[1]
Acuna M. J., 2019, Angiotensin-(1-7): A comprehensive review, P169, DOI [10.1007/978-3-030-22696-111, DOI 10.1007/978-3-030-22696-111]
[2]
Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer [J].
Akanji, Musbau Adewumi ;
Rotimi, Damilare ;
Adeyemi, Oluyomi Stephen .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
[3]
Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy [J].
Alvarez, K ;
Fadic, R ;
Brandan, E .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 85 (04) :703-713
[4]
Physiological activation of hypoxia inducible factor-1 in human skeletal muscle [J].
Ameln, H ;
Gustafsson, T ;
Sundberg, CJ ;
Okamoto, K ;
Jansson, E ;
Poellinger, L ;
Makino, Y .
FASEB JOURNAL, 2005, 19 (06) :1009-+
[6]
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism [J].
Aragones, Julian ;
Schneider, Martin ;
Van Geyte, Katie ;
Fraisl, Peter ;
Dresselaers, Tom ;
Mazzone, Massimiliano ;
Dirkx, Ruud ;
Zacchigna, Serena ;
Lemieux, Helene ;
Jeoung, Nam Ho ;
Lambrechts, Diether ;
Bishop, Tammie ;
Lafuste, Peggy ;
Diez-Juan, Antonio ;
Harten, Sarah K. ;
Van Noten, Pieter ;
De Bock, Katrien ;
Willam, Carsten ;
Tjwa, Marc ;
Grosfeld, Alexandra ;
Navet, Rachel ;
Moons, Lieve ;
Vandendriessche, Thierry ;
Deroose, Christophe ;
Wijeyekoon, Bhathiya ;
Nuyts, Johan ;
Jordan, Benedicte ;
Silasi-Mansat, Robert ;
Lupu, Florea ;
Dewerchin, Mieke ;
Pugh, Chris ;
Salmon, Phil ;
Mortelmans, Luc ;
Gallez, Bernard ;
Gorus, Frans ;
Buyse, Johan ;
Sluse, Francis ;
Harris, Robert A. ;
Gnaiger, Erich ;
Hespel, Peter ;
Van Hecke, Paul ;
Schuit, Frans ;
Van Veldhoven, Paul ;
Ratcliffe, Peter ;
Baes, Myriam ;
Maxwell, Patrick ;
Carmeliet, Peter .
NATURE GENETICS, 2008, 40 (02) :170-180
[7]
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure [J].
Arendse, Lauren B. ;
Danser, A. H. Jan ;
Poglitsch, Marko ;
Touyz, Rhian M. ;
Burnett, John C., Jr. ;
Llorens-Cortes, Catherine ;
Ehlers, Mario R. ;
Sturrock, Edward D. .
PHARMACOLOGICAL REVIEWS, 2019, 71 (04) :539-570
[8]
Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo [J].
Arsic, N ;
Zacchigna, S ;
Zentilin, L ;
Ramirez-Correa, G ;
Pattarini, L ;
Salvi, A ;
Sinagra, G ;
Giacca, M .
MOLECULAR THERAPY, 2004, 10 (05) :844-854
[9]
Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy [J].
Au, Carol G. ;
Butler, Tanya L. ;
Sherwood, Megan C. ;
Egan, Jonathan R. ;
North, Kathryn N. ;
Winlaw, David S. .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2011, 92 (01) :57-65
[10]
Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy [J].
Bauer, Ralf ;
Straub, Volker ;
Blain, Alison ;
Bushby, Kate ;
MacGowan, Guy A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (05) :463-471